Avoiding analgesic escalation and excessive healthcare utilization in severe irritable bowel syndrome: a role for intramuscular anticholinergics?

被引:6
作者
Pearson, James S. [1 ]
Pollard, Christine [1 ]
Whorwell, Peter J. [1 ]
机构
[1] Univ Manchester, Ctr Gastrointestinal Sci, Inst Inflammat & Repair, Neurogastroenterol Unit, Manchester, Lancs, England
关键词
intramuscular hyoscine butylbromide; irritable bowel syndrome; narcotic bowel syndrome; METAANALYSIS; DIAGNOSIS; MANAGEMENT; DISORDERS; FEATURES;
D O I
10.1177/1756283X14540028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: In patients with severe irritable bowel syndrome (IBS), abdominal pain can be the predominant symptom impacting on all aspects of their lives and resulting in excessive healthcare utilization. Furthermore, the use of analgesics can become excessive in this group of patients, sometimes leading to opiate dependency. Typically, the pain is often described as spastic in nature and we have speculated that parenteral anticholinergics might provide effective relief when all other measures have failed. For several years, we have therefore been asking general practitioners to consider teaching such patients to administer intramuscular hyoscine butylbromide for pain episodes and this study is an audit of this approach. Methods: Patients in whom the use of intramuscular hyoscine butylbromide had been recommended to their general practitioner in the last three years were interviewed over the telephone in order to document the efficacy of this approach as well as any potential disadvantages. Results: A total of 122 general practitioners were advised to try this approach, with 58 agreeing to teach the technique and prescribe the medication. Of the 58 patients who used the medication, 50 (86%) found it gave them pain relief, which was complete in six (10%), substantial in 36 (62%) and mild in eight (14%), with 15 (26%) decreasing the use of analgesics and 13 (32%) of the 41 taking opiates able to reduce or stop them completely. Side effects were few and largely consisted of those associated with anticholinergics. Only four patients stopped medication because of side effects and no major skin reactions were reported. Conclusions: The use of intramuscular hyoscine butylbromide shows promise in the management of IBS when severe unmanageable abdominal pain is a major problem. This approach appears to be safe and has the potential to reduce analgesic escalation, opiate dependency and attendances at accident and emergency departments.
引用
收藏
页码:232 / 237
页数:6
相关论文
共 17 条
  • [1] Evidence of Central and Peripheral Sensitization in a Rat Model of Narcotic Bowel-Like Syndrome
    Agostini, Simona
    Eutamene, Helene
    Cartier, Christel
    Broccardo, Maria
    Improta, Giovanna
    Houdeau, Eric
    Petrella, Carla
    Ferrier, Laurent
    Theodorou, Vassillia
    Bueno, Lionel
    [J]. GASTROENTEROLOGY, 2010, 139 (02) : 553 - 563
  • [2] BMJ learning - Irritable bowel syndrome: diagnosis and management
    Agrawal, A
    Whorwell, PJ
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7536): : 280 - 283
  • [3] Opioid Bowel Dysfunction and Narcotic Bowel Syndrome: A Population-Based Study
    Choung, Rok Seon
    Locke, G. Richard, III
    Zinsmeister, Alan R.
    Schleck, Cathy D.
    Talley, Nicholas J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (05) : 1199 - 1204
  • [4] Diagnosis, Characterization, and 3-Month Outcome After Detoxification of 39 Patients With Narcotic Bowel Syndrome
    Drossman, Douglas A.
    Morris, Carolyn B.
    Edwards, Hollie
    Wrennall, Christina E. D.
    Weinland, Stephan R.
    Aderoju, Ademola O.
    Kulkarni-Kelapure, Renuka R.
    Hu, Yuming J.
    Dalton, Christine
    Bouma, Megan H.
    Zimmerman, Joseph
    Rooker, Ceciel
    Leserman, Jane
    Bangdiwala, Shrikant I.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (09) : 1426 - 1440
  • [5] eMC, 2013, BUSC EL MED COMP
  • [6] Opioids and the Gastrointestinal Tract - A Case of Narcotic Bowel Syndrome and Literature Review
    Farmer, Adam D.
    Ferdinand, Ella
    Aziz, Qasim
    [J]. JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2013, 19 (01) : 94 - 98
  • [7] Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
    Ford, A. C.
    Talley, N. J.
    Schoenfeld, P. S.
    Quigley, E. M. M.
    Moayyedi, P.
    [J]. GUT, 2009, 58 (03) : 367 - 378
  • [8] Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis
    Ford, Alexander C.
    Talley, Nicholas J.
    Spiegel, Brennan M. R.
    Foxx-Orenstein, Amy E.
    Schiller, Lawrence
    Quigley, Eamonn M. M.
    Moayyedi, Paul
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 : 1388 - 1392
  • [9] The narcotic bowel syndrome: Clinical features, pathophysiology, and management
    Grunkemeier, David M. S.
    Cassara, Joseph E.
    Dalton, Christine B.
    Drossman, Douglas A.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (10) : 1126 - 1139
  • [10] Effect of a second-generation α2δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome
    Houghton, L. A.
    Fell, C.
    Whorwell, P. J.
    Jones, I.
    Sudworth, D. P.
    Gale, J. D.
    [J]. GUT, 2007, 56 (09) : 1218 - 1225